We seek to understand the mechanisms that trigger various types of cancers. We’re developing new treatment approaches — including the development of a new implantable device designed to catch circulating cells before they become tumors, and a novel use of cryoablation as an alternative to surgery for patients with early-stage breast cancer. Additionally, we’re investigating the link between the genetic regulation of stem cells and the role this may play in adrenal cancers — a vital first step toward finding better treatments.
Programs & Investigators
- Cho Lab
- Lubman Lab
- Pasca di Magliano Lab
- Endocrine Oncology Program
- Clifford S. Cho, MD, FACS
- Mark S. Cohen, MD
- Timothy Frankel, MD
- Karin Hardiman, MD
- Jacqueline Jeruss, MD, PhD
- Qiao Li, PhD
- Marina Pasca di Magliano, PhD
- Michael S. Sabel, MD
- Chitra Subramanian, PhD, MBA
- Shuang Wei, PhD
- Yaqing Zhang, MD, PhD